Rafael Assis
Overview
Explore the profile of Rafael Assis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Americo M, Dos Santos Freitas A, da Silva T, Lima de Jesus L, Barroso F, Campos G, et al.
Front Microbiol
. 2023 May;
14:1157544.
PMID: 37138633
Mucositis is an inflammation of the gastrointestinal mucosa that debilitate the quality of life of patients undergoing chemotherapy treatments. In this context, antineoplastic drugs, such as 5-fluorouracil, provokes ulcerations in...
2.
Khan S, Hosseinian S, Assis R, Khalil G, Luu M, Jain A, et al.
Res Sq
. 2022 Dec;
PMID: 36561177
In the context of recurrent surges of SARS-CoV-2 infections, a detailed characterization of antibody persistence over a 6-month period following vaccine booster dose is necessary to crafting effective public health...
3.
Goll J, Jain A, Jensen T, Assis R, Nakajima R, Jasinskas A, et al.
NPJ Vaccines
. 2022 Aug;
7(1):103.
PMID: 36042229
Current seasonal and pre-pandemic influenza vaccines induce short-lived predominantly strain-specific and limited heterosubtypic responses. To better understand how vaccine adjuvants AS03 and MF59 may provide improved antibody responses to vaccination,...
4.
Gohil S, Quan K, Madey K, King-Adelsohn S, Tjoa T, Tifrea D, et al.
Antimicrob Resist Infect Control
. 2021 Nov;
10(1):163.
PMID: 34809702
Background: Early evaluations of healthcare professional (HCP) COVID-19 risk occurred during insufficient personal protective equipment and disproportionate testing, contributing to perceptions of high patient-care related HCP risk. We evaluated HCP...
5.
Assis R, Jain A, Nakajima R, Jasinskas A, Khan S, Palma A, et al.
NPJ Vaccines
. 2021 Nov;
6(1):132.
PMID: 34737318
We analyzed data from two ongoing COVID-19 longitudinal serological surveys in Orange County, CA., between April 2020 and March 2021. A total of 8476 finger stick blood specimens were collected...
6.
Assis R, Jain A, Nakajima R, Jasinskas A, Khan S, Davies H, et al.
Sci Rep
. 2021 Apr;
11(1):7554.
PMID: 33824382
A coronavirus antigen microarray (COVAM) was constructed containing 11 SARS-CoV-2, 5 SARS-1, 5 MERS, and 12 seasonal coronavirus recombinant proteins. The array is designed to measure immunoglobulin isotype and subtype...